Screening for Substance Use Disorders during Pregnancy: A Decision at the Intersection of Racial and Reproductive Justice.
Am J Perinatol
; 40(6): 598-601, 2023 04.
Article
em En
| MEDLINE
| ID: mdl-34891192
ABSTRACT
OBJECTIVE:
Improve racial equity with routine universal drug screening / StudyDesign:
Commentary on the medicolegal and social history of the United States and the field of obstetrics and gynecology regarding drug screening policy /Results:
Critical aspects to inform an equitable drug screening policy include (1) racial bias and stigma related to substance use, (2) the legislative history surrounding substance use during pregnancy, (3) the relationship between substance use and mass incarceration which disproportionately affects persons of color, (4) propensity toward punitive measures for Black mothers with substance use, including termination of parental rights, (5) the role of the medical field in fostering mistrust among our patients /Conclusion:
new practices in screening for substance use during pregnancy are needed. KEY POINTS · Increasing demand for racial justice warrants reframing the issue of urine drug screening.. · The current legal constructs continue to disproportionately impact women of color.. · Routine verbal screening can replace urine drug screening and diminish implicit biases..
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Transtornos Relacionados ao Uso de Substâncias
/
Ginecologia
/
Obstetrícia
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limite:
Female
/
Humans
/
Pregnancy
País como assunto:
America do norte
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article